Pharmaceutical Supply – Haloperidol Injection (NDC 00054-0017-12)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the supply of one unit of Haloperidol Injection, USP 5 mg/mL in 2 mL single-dose vials, identified by NSN 6505-01-694-5455 and NDC 00054-0017-12, an FDA-approved psychiatric medication available in commercial off-the-shelf form. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with the NAICS code 325412 indicating pharmaceutical manufacturing. The contract was posted on July 17, 2026, and the specific delivery details are linked to award SPE2DX25D9822 and delivery order SPE2D226F3057. No set-aside provisions are specified, and the place of performance and point of contact information are not provided, but the supply is intended for defense-related medical use. The medication is packaged in single-dose vials, meeting standard commercial specifications for pharmaceutical procurement by federal agencies.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
